ARID1A Antibodies

Santa Cruz Biotechnology offers a broad range of ARID1A monoclonal antibodies for research focused on understanding ARID1A protein's role in various biological processes. ARID1A monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ARID1A, a key component of the SWI/SNF chromatin remodeling complex, plays a crucial role in regulating gene expression and maintaining genomic stability. Mutations in the ARID1A gene have been implicated in several cancers, making it an important target for cancer research. Understanding ARID1A function is essential for elucidating its involvement in tumorigenesis and developing potential therapeutic strategies. ARID1A monoclonal antibodies enable precise detection and analysis of ARID1A expression patterns across different cell types and tissues. Researchers can investigate ARID1A's role in cell cycle regulation, DNA repair mechanisms, and chromatin organization. Advanced visualization techniques using ARID1A monoclonal antibodies help map protein interactions and cellular localization patterns. Santa Cruz Biotechnology monoclonal antibodies for ARID1A research support scientists worldwide in advancing our understanding of cancer biology and therapeutic development.